VOR VOR BIOPHARMA
Health Care · Russell 2000
Next earnings: not announced yet
What 12 analyst firms say about VOR BIOPHARMA: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
11 rated views · 12 analyst/firm records · 12 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8044
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8031
Recent analyst activity · last 90 days
Our tracked history has 6 reports on VOR from 5 analyst firms in the last 90 days (12 firms in the past year).
Comparing each firm's latest target with its previous one: 3 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wedbush raised its target from $18.00 (set 14 May 2026) to $27.00 on 11 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Jack K Allen | Buy | 1 Jun 2026 | 46.00 USD |
| Citigroup | Geoff Meacham | Buy | 15 Oct 2026 | 50.00 USD |
| Citizens JMP | Silvan C Tuerkcan | Hold | 1 Jul 2026 | — |
| H.C. Wainwright | Swayampakula Ramakanth | Buy | 12 Aug 2026 | 31.00 USD |
| Jefferies | Farzin Haque | Buy | 30 Apr 2026 | 48.00 USD |
| JPMorgan | Anupam Rama | Buy | 19 Dec 2025 | 40.00 USD |
| TD Cowen | Yaron Werber | Buy | 15 Jun 2026 | — |
| Wedbush | Martin Fan | Hold | 12 Aug 2026 | 27.00 USD |
| Weiss Ratings | Unnamed analyst | — | 14 Sep 2026 | — |
| Wells Fargo | Sadia Rahman | Buy | 19 Mar 2026 | 30.00 USD |
| William Blair | Myles Minter | Buy | 21 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 28 May 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.